PFE - Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? | Benzinga
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization for the company's Covid-19 vaccine, Adjuvanted (2023-2024 Formula) to prevent Covid in individuals aged 12 and older.
What To Know: The FDA has authorized the updated version of Novavax's protein-based Covid-19 vaccine for emergency use in individuals 12 years of age and older, per Reuters.
The news comes ...